Table 3 Adjusted relative risk of ATPIII-defined metabolic syndrome components by weight change groups in men (n = 1431)*
From: Weight change and incident metabolic syndrome in Iranian men and women; a 3 year follow-up study
| Â | Percentage of weight change | ||||
|---|---|---|---|---|---|
|  | Loss group (<-1.3%) | Stable group (-1.3 to 1.3%) | Mild gain group (1.4 to 3.9%) | Moderate gain group (4 to 6.9%) | Large gain group (≥ 7%) |
High WC | 0.3 (0.1–0.6) | Reference | 2.4 (1.3–4.4) | 4.4 (2.4–8.0) | 9.2 (4.8–17.5) |
No. of subjects†| 255 | 236 | 263 | 240 | 276 |
P value | 0.001 | Â | 0.005 | < 0.001 | < 0.001 |
High TG | 0.8 (0.4–1.9) | Reference | 2.2 (1.1–4.5) | 1.9 (0.9–3.8) | 3.8 (1.9–7.7) |
No. of subjects†| 111 | 103 | 116 | 126 | 168 |
P value | 0.7 | Â | 0.03 | 0.08 | < 0.001 |
Low HDL-C | 0.8 (0.4–1.4) | Reference | 0.9 (0.5–1.6) | 1.3 (0.7–2.5) | 1.9 (1.0–3.4) |
No. of subjects†| 99 | 93 | 108 | 94 | 117 |
P value | 0.4 | Â | 0.8 | 0.3 | 0.04 |
High FPG | 0.5 (0.2–1.2) | Reference | 1.4 (0.7–2.8) | 1.2 (0.6–2.5) | 1.3 (0.6–2.9) |
No. of subjects†| 236 | 234 | 265 | 248 | 281 |
P value | 0.1 | Â | 0.3 | 0.6 | 0.4 |
High BP | 1.2 (0.6–2.7) | Reference | 1.8 (0.8–3.7) | 2.7 (1.3–5.6) | 3.4 (1.7–7.1) |
No. of subjects†| 155 | 160 | 175 | 176 | 225 |
P value | 0.6 | Â | 0.1 | 0.007 | 0.001 |